(773) 962-3900
Locations
New Patient Portal

What Clinicians Need to Know About Oral Antiviral Medications for COVID-19

Home · What Clinicians Need to Know About Oral Antiviral Medications for COVID-19

What Clinicians Need to Know About Oral Antiviral Medications for COVID-19

The emergency use authorizations (EUAs) for the new oral antiviral medications molnupiravir and Paxlovid(TM) (nirmatrelvir/ritonavir) supplement current therapeutic efforts to decrease hospitalizations and prevent severe COVID-19 and death. During this COCA Call, presenters from CDC, ASPR, FDA, and NIH will describe the recent EUAs and NIH treatment guidelines, patient prioritization, and resources for healthcare providers.

This video can also be viewed at

Powered by Americaneagle.com
Scroll to Top